Speaker Profile
M.D., Chief. Early Phase Drug Development, SCRI
Biography
Vivek Subbiah, MD, joined Sarah Cannon Research Institute (SCRI) in 2023, and serves as chief, EarlyPhase Drug Development. In his role, Dr. Subbiah oversees SCRIs nine drug development units and leads the expansion of earlyphase capabilities and programs across SCRIs growing research network. Dr. Vivek Subbiah comes to SCRI from the University of Texas MD Anderson Cancer Center where he was an associate professor in the Department of Investigational Cancer Therapeutics. During his near 15year tenure there, Dr. Vivek Subbiah held several leadership roles including executive director, Medical Oncology Research, MD Anderson Cancer Network as well as clinical medical director, Division of Cancer Medicine where he oversaw both the outpatient and inpatient clinical care delivery operations for the Phase I program.Dr. Vivek Subbiah has served as the principal investigator in over 100 phase III trials and coinvestigator in over 200 clinical trials
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2024 Award Ceremony:
Luminary Honoree: Catriona Jamieson, UCSD Health
- Targeting Cancer Stem Cells in Precision Oncology
- Catriona Jamieson, UCSD Health
- Revolutionizing Clinical Trials: Precision Oncology and Novel Trial Designs (PANEL)
Chair: Razelle Kurzrock, MCW
- Vivek Subbiah, Sarah Cannon Research Institute (SCRI)
- Andrea Cercek, Memorial Sloan Kettering
- Ben George, MCW
- Patricia LoRusso, Yale - Transcriptomics in Precision Oncology: Opportunities and Limitations (PANEL)
Chair: Razelle Kurzrock, MCW
- Charles Perou, University of North Carolina
- Eytan Ruppin, NIH
- Bruce Quinn, Bruce Quinn Assoc LL
- Andrea Califano, Columbia University - Democratizing Access to Personalized Cancer Care: The Role of Biomarker Testing (PANEL)
Chair: Maggie Rougier-Chapman, Labcorp
- Antibody-Drug Conjugates (ADCs): Tracing the Evolution and Forecasting the Future (PANEL)
Chair: Adrian Lee, UPMC
- Sandhya Girish, Gilead
- Neelima Denduluri, Astra Zeneca
- Hope S. Rugo, UCSF - PMWC Showcase
- Michael Milburn, Genecentric Tx
